RTSM is evolving into a precision engine for clinical supply, aligning real-time trial activity with smarter planning, lower waste, and faster operational decisions.
- Designing CNS Trial Supply Chains: A Technical Framework
- Primary Healthcare Disruption And Clinical Trial Supply Risk
- Protecting Clinical Trials From Global Supply Disruptions
- From Passive To Predictive: The New Era Of Clinical Cold Chain Management
- When Shipments Stop: Understanding And Managing Customs Delays In Clinical Supply Chains
- U.S. Pharma Tariffs And MFN Become Law After April 2 Update
- 6 Risks To Clinical Supply Spurred By 'Once In A Lifetime' Lp(a) Screening
- Where Trial Budgets And Supply Plans Go Off Track — Earlier Than You Think
ON-DEMAND WEBINARS
The complexities of sample collection and logistics in advanced therapy studies naturally brings chain of custody challenges in protecting the integrity of a trials’ high value samples. Learn about end to end sample management strategies, logistical integration planning, real-time tracking and LIVE monitoring technologies.
Learn about strategies that can help build an understanding of risk assessment, in addition to how a study’s protocol requirements, packaging specifications, and more must be identified and addressed.
Master clinical trial success by integrating IRT and RTSM through Quality by Design. Learn to proactively manage complexities, reduce operational risk, and ensure seamless global compliance.
Join Neta Bendelac from 4G Clinical and Limor Teomim from IMP CSS for an informative webinar as they explore how to mitigate the growing challenges faced as a result of the pandemic when it comes to DtP strategies and virtual trial design.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![iStock-1219082584-delivery-direct-logistics]( "How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End Solution")
How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End SolutionAnalyze the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency, and accelerate speed to market.
-
![iStock-635767756-clinical-trial-research]( "Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply Chain")
Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply ChainFlexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.
-
![Vials pharma manufacturing GettyImages-618518692]( "Planning Your Packaging For A Seamless Transition From Clinic To Launch")
Planning Your Packaging For A Seamless Transition From Clinic To LaunchExplore how clinical and commercial teams should work together for clinical supply packaging, how the COVID-19 pandemic has changed things, and what to consider when looking for a packaging partner.
-
![GettyImages-1751848523-meeting-evaluation-charts-table]( "Writing Effective Clinical Regulatory Documents For Therapy Trials")
Writing Effective Clinical Regulatory Documents For Therapy TrialsClinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.
-
![GettyImages-1070902452-planning-tracking-packaging-shipment]( "Winning The Race To FPI With Early Randomization And Trial Supply Management")
Winning The Race To FPI With Early Randomization And Trial Supply ManagementLearn why the ability to get investigational products to sites, and appropriately store them, is not a given – and this oversight can have serious consequences.
-
![BO 2 - GC_App_^CZ vial with stopper and seal stack up]( "Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization")
Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To CommercializationWhile in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.
-
![Medical-Research-laborratory-GettyImages-1354172439]( "Investigational Medicinal Products: Labeling Changes And Their Implications")
Investigational Medicinal Products: Labeling Changes And Their ImplicationsLearn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.
-
![Getty-1652511983-supply-chain-management]( "Increasing Efficiency And Reducing Drug Waste")
Increasing Efficiency And Reducing Drug WasteDiscover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.
-
![GettyImages-1764818961 warehouse, storage, inventory]( "GxP Inventory Solution Delivers Real-Time Visibility, Operational Efficiency")
GxP Inventory Solution Delivers Real-Time Visibility, Operational EfficiencyExplore how unified forecasting and GxP-level inventory control can streamline your clinical supply chain, reduce risk, and strengthen oversight across every trial you run.
-
![gettyimages-946264212-170667a]( "Navigate Complex Ancillary Supply Sourcing Challenges")
Navigate Complex Ancillary Supply Sourcing ChallengesExplore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
